HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Delayed onset of pseudomembranous colitis after rifampin therapy.

Abstract
Rifampin therapy is an infrequently reported cause of pseudomembranous colitis. A low index of suspicion may account for this lack of recognition. Awareness of this potentially hazardous complication of rifampin therapy is encouraged, especially since increasing numbers of patients infected with the human immunodeficiency virus, who may have diarrhea from other etiologies, require rifampin therapy.
AuthorsR P Byrd Jr, T M Roy, M A Ossorio, C L Fields
JournalSouthern medical journal (South Med J) Vol. 90 Issue 6 Pg. 644-6 (Jun 1997) ISSN: 0038-4348 [Print] United States
PMID9191744 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Antibiotics, Antitubercular
  • Antidiarrheals
  • Metronidazole
  • Rifampin
Topics
  • Antibiotics, Antitubercular (adverse effects)
  • Antidiarrheals (therapeutic use)
  • Clostridioides difficile (isolation & purification)
  • Diagnosis, Differential
  • Diarrhea (chemically induced, drug therapy, microbiology)
  • Enterocolitis, Pseudomembranous (chemically induced, drug therapy, microbiology)
  • HIV Enteropathy (diagnosis)
  • Humans
  • Male
  • Metronidazole (therapeutic use)
  • Middle Aged
  • Rifampin (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: